Value of breast cancer molecular subtypes and Ki67 expression for the prediction of efficacy and prognosis of neoadjuvant chemotherapy in a Chinese population.

被引：0
|
作者：
Wang, Jiayu
Xu, Binghe
Sang, Die
Zhang, Pin
Li, Qing
Yuan, Peng
Ma, Fei
Luo, Yang
Fan, Ying
Cai, Ruigang
Chen, Shanshan
Li, Qiao
机构：
[1] Chinese Acad Med Sci, Canc Hosp & Inst, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Canc Hosp, Beijing, Peoples R China
[4] Beijing Sanhuan Canc Hosp, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing, Peoples R China
[6] Chinese Acad Med Sci CAMS, Canc Hosp, Dept Med Oncol, Beijing, Peoples R China
[7] Chinese Acad Med Sci, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e12512
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12512
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
    Stathopoulos, George P.
    Malamos, Nikolaos A.
    Markopoulos, Christos
    Polychronis, Athanasios
    Armakolas, Athanasios
    Rigatos, Sotirios
    Yannopoulou, Anna
    Kaparelou, Maria
    Antoniou, Photini
    ANTI-CANCER DRUGS, 2014, 25 (08) : 950 - 957
  • [32] Predicting Outcome with Ki67 in Primary Breast Cancer in the Neoadjuvant Setting
    Li, S. P.
    Burcombe, R.
    Beresford, M. J.
    Kornbrot, D. E.
    Seah, M-L
    Ostler, P. J.
    Wilson, G. D.
    Makris, A.
    CANCER RESEARCH, 2010, 70
  • [33] Prognostic value of Ki67 expression in post-treatment tumors of patients with residual triple-negative breast cancer after neoadjuvant chemotherapy
    Kook, Yoonwon
    Lee, Soo-Young
    Baek, Seung Ho
    Kim, Min Ji
    Kim, Junghyun
    Moon, Sohyun
    Lee, Seung Eun
    Bae, Soong June
    Jeong, Joon
    Lee, Sae Byul
    Ahn, Sung Gwe
    CANCER RESEARCH, 2024, 84 (09)
  • [34] Value of Ki67 in breast cancer: the debate is still open
    Colozza, Mariantonietta
    Sidoni, Angelo
    Piccart-Gebhart, Martine
    LANCET ONCOLOGY, 2010, 11 (05): : 414 - 415
  • [35] Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy
    Cabrera-Galeana, Paula
    Munoz-Montano, Wendy
    Lara-Medina, Fernando
    Alvarado-Miranda, Alberto
    Perez-Sanchez, Victor
    Villarreal-Garza, Cynthia
    Marisol Quintero, R.
    Porras-Reyes, Fany
    Bargallo-Rocha, Enrique
    Del Carmen, Ignacio
    Mohar, Alejandro
    Arrieta, Oscar
    ONCOLOGIST, 2018, 23 (06): : 670 - 678
  • [36] Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer: Effects of Age and Tumor Ki67
    Boughey, Judy C.
    Hoskin, Tanya L.
    Goetz, Matthew P.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (09) : 5747 - 5756
  • [37] Prognostic (Px) significance of Ki67 before and after neoadjuvant chemotherapy (CT) in early breast cancer
    Jones, R. L.
    Salter, J.
    Nerurkar, A.
    Parton, M.
    A'Hern, R.
    Smith, I. E.
    Dowsett, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer: effects of Age and Tumor ki67
    Matar, Regina
    Boughey, Judy C.
    Hoskin, Tanya
    Goetz, Matthew P.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 338 - 339
  • [39] Evaluation of Ki67 proliferation index before and during neoadjuvant chemotherapy for primary breast cancer.
    Burcombe, RJ
    Makris, A
    Richman, PI
    Daley, F
    Pittam, M
    Wilson, GD
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S67 - S67
  • [40] Breast cancer Ki67 expression prediction by DCE-MRI radiomics features
    Ma, W.
    Ji, Y.
    Qi, L.
    Guo, X.
    Jian, X.
    Liu, P.
    CLINICAL RADIOLOGY, 2018, 73 (10) : 909.e1 - 909.e5
12345